RCC/Renal Cell Carcinoma, Kidney Cancer News Articles

Renal Cell Carcinoma News

RENAL CELL CARCINOMA ADVISOR

Renal Cell Carcinoma News

Ongoing studies are expected to provide information about how to sequence cabozantinib in clinical p

Elevated NLR Combined With Low Sodium Predicts Worse Survival in RCC

At RCC diagnosis, patients with an neutrophil-lymphocyte ratio (NLR) above 3.0 and concomitant hyponatremia had a significant 2.8-fold increased risk of death compared with those who had an NLR of 3.0 or lower and normal sodium levels, a Danish study found.

Time on mRCC Drug Linked to Survival

Within the first 2 lines of treatment, patients with metastatic renal cell carcinoma who remain on a drug for at least 3 months have longer overall survival than those who do not, a study found.